Altai Protocol Library
1041 protocols and counting
All protocols with references and links
All protocols reviewed by a Medical Oncologist/Hematologist
All protocols in major guidelines included
Ability to create your own protocols
New indication: Olutasidenib for relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation
New indication: Olutasidenib for relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation | |
---|---|
Study: |
|
Efficacy: |
|
Safety: |
|
Lancet Haematol. 2023 Jan;10(1): e46-e58. Watts M J.et al. Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial https://doi.org/10.1016/S2352-3026(22)00292-7 Reviewed by Elvin CHALABİYEV, MD on Jan 30, 2023 |
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.